Sherbrooke Park Advisers’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,786	Closed	-$200K	–	600
2024 Q4	$200K	Buy	+11,786	New	+$200K	0.06%	594
2024 Q3	–	Sell	-19,922	Closed	-$485K	–	899
2024 Q2	$485K	Buy	+19,922	New	+$485K	0.08%	425